Search results
Author(s):
Michael Haude
Added:
3 years ago
Myocardial infarction (MI) is the leading cause of death worldwide in both men and women.1 An impending infarction is recognised by ST elevation, which is predominantly the result of an occlusive thrombosis in a coronary artery. An immediate goal in MI is to restore blood flow through the occluded coronary artery. Reperfusion is carried out using primary percutaneous coronary intervention (PCI)…
View more
Author(s):
Dariusz Jagielak
,
Radoslaw Targonski
,
Dariusz Ciecwierz
Added:
3 years ago
1. Interventional Cardiology Review 2021;16(Suppl 1):1–4. DOI:https://doi.org/10.15420/icr.2021.S1
View more
Trans-catheter Aortic Valve Implantation Guidelines - Does the Latest Evidence Change our Views?
Author(s):
Hannah McConkey
,
Bernard Prendergast
Added:
3 years ago
Article
Author(s):
Matthew Price
Added:
7 years ago
Author(s):
Dean J Kereiakes
Added:
3 years ago
Diabetes and the associated metabolic syndrome have reached epidemic proportions in many areas of the world.1,2 Atherosclerotic cardiovascular disease has been correlated with the presence, duration and severity of diabetes.3,4 Patients with diabetes have worse clinical outcomes following presentation for acute coronary syndrome (ACS)5,6 as well as following both surgical (coronary artery bypass…
View more
Author(s):
Jan Balzer
,
Tobias Zeus
,
Verena Veulemans
,
et al
Added:
3 years ago
Percutaneous catheter-based structural heart disease procedures are a rapidly growing area of interventional cardiology, and represent a valuable option for cardiac patients with comorbidities who are ineligible for conventional surgery as well as demonstrating excellent outcomes.1,2 Catheter-based interventions include transcatheter aortic valve implantation (TAVI),3 percutaneous mitral valve …
View more
Catheter-based Renal Denervation
Author(s):
Philipp Lurz
,
Karl Fengler
Added:
3 years ago
Article
Author(s):
Katrina Mountfort
Added:
3 years ago
Hypertension is one of the most important public health problems of the 21st century, with a global prevalence of around 30 %.1 In 2010, it accounted for 7.5 million deaths worldwide, representing 12.8 % of the global total.2 Furthermore, its prevalence is projected to rise to 1.5 billion hypertensive patients in 2025.3 Despite the availability of numerous safe and effective antihypertensive…
View more
Author(s):
Matthew Price
Added:
6 years ago